Find the latest in EPAD news and research
-
Read more: Alzheimer’s Research & Therapy
“Polygenic pathways shape white matter vulnerability to Alzheimer’s disease-related pathophysiological changes” Authors: Mario Tranfa, Leonard Pieperhoff, Giuseppe Pontillo, Emma S. Luckett, Lyduine E. Collij, Tiago Gil Oliveira, Niccoló Tesi, Natalia…
All news and research
-
|
The scientific director of the Alzheimer’s Prevention Research Program at the Barcelonaβeta Brain Research Center, José Luis Molinuevo, presented in Japan…
-
|
The European Prevention of Alzheimer’s Dementia Consortium (EPAD) seeks a Communications and Events Officer (part-time: 18.75 hours/50% FTE). The post is…
-
|
On 7 June, the Gerontopole of Toulouse University Hospital organised a concert honouring Claude Nougaro for the EPAD research participants in Toulouse…
-
|
We are delighted to announce that 75 new research participants were enrolled in the EPAD Longitudinal Cohort Study (LCS) in May.…
-
|
This year, the European Prevention of Alzheimer’s Dementia (EPAD) general assembly meeting was held in Amsterdam, under the banner “How…
-
|
Imaging in AD_latest developments, Frederik Barkhof
-
|
Our sister project, Amyloid imaging to prevent Alzheimer’s disease (AMYPAD), which began its activities on October 2016, has recently enrolled its first…
-
|
We are delighted to announce that April was the most successful month to date with 73 new research participants enrolled in the…
-
|
What is your current role in EPAD? I coordinate EPAD at the Edinburgh Trial Delivery Centre, working with a great team…
-
|
The first quarter of 2018 started with great intensity! We were busy working towards opening new sites and improving recruitment. Positive…
-
|
What is your current role in EPAD? As a Data Scientist at Aridhia, I support the development and maintenance of the…
-
|
Dr Vanessa Raymont (pictured) is a senior researcher and consultant psychiatrist working in the Department of Psychiatry at the University of…
-
|
Summary: Biomedical research aimed at the development of therapies for chronic and late‐onset conditions increasingly concentrates on the early treatment of…
-
At, with and beyond risk: expectations of living withthe possibility of future dementia
-
|
We are delighted to announce that March was the most successful month to date with 66 new research participants enrolled in…
-
|
ABSTRACT: Introduction: It is a challenge to find participants for Alzheimer’s disease (AD) prevention trials within a short period of time.…
-
European Prevention of Alzheimer’s Dementia Registry:Recruitment and prescreening approach for a longitudinalcohort and prevention trials
-
|
On 22 March, The Lancet Neurology published an article entitled: “Frederik Barkhof: building bridges between disciplines” where EPAD and its sister…
-
|
CSF Biomarkers in AD, José Luis Molinuevo
-
|
The IMI-EMIF initiative would like to invite you to its public symposium: ‘Liberating Evidence from European Health Data – the Achievements and…
-
The Rationale Behind the New Alzheimer’s DiseaseConceptualization: Lessons Learned During the LastDecades
No posts were found.
No posts were found.